» Articles » PMID: 36232871

A Comprehensive Review on Beneficial Effects of Catechins on Secondary Mitochondrial Diseases

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Oct 14
PMID 36232871
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondria are the main sites for oxidative phosphorylation and synthesis of adenosine triphosphate in cells, and are known as cellular power factories. The phrase "secondary mitochondrial diseases" essentially refers to any abnormal mitochondrial function other than primary mitochondrial diseases, i.e., the process caused by the genes encoding the electron transport chain (ETC) proteins directly or impacting the production of the machinery needed for ETC. Mitochondrial diseases can cause adenosine triphosphate (ATP) synthesis disorder, an increase in oxygen free radicals, and intracellular redox imbalance. It can also induce apoptosis and, eventually, multi-system damage, which leads to neurodegenerative disease. The catechin compounds rich in tea have attracted much attention due to their effective antioxidant activity. Catechins, especially acetylated catechins such as epicatechin gallate (ECG) and epigallocatechin gallate (EGCG), are able to protect mitochondria from reactive oxygen species. This review focuses on the role of catechins in regulating cell homeostasis, in which catechins act as a free radical scavenger and metal ion chelator, their protective mechanism on mitochondria, and the protective effect of catechins on mitochondrial deoxyribonucleic acid (DNA). This review highlights catechins and their effects on mitochondrial functional metabolic networks: regulating mitochondrial function and biogenesis, improving insulin resistance, regulating intracellular calcium homeostasis, and regulating epigenetic processes. Finally, the indirect beneficial effects of catechins on mitochondrial diseases are also illustrated by the warburg and the apoptosis effect. Some possible mechanisms are shown graphically. In addition, the bioavailability of catechins and peracetylated-catechins, free radical scavenging activity, mitochondrial activation ability of the high-molecular-weight polyphenol, and the mitochondrial activation factor were also discussed.

Citing Articles

Bee Pollen Phytochemicals and Nutrients as Unequaled Pool of Epigenetic Regulators: Implications for Age-Related Diseases.

Kacemi R, Campos M Foods. 2025; 14(3).

PMID: 39941940 PMC: 11816923. DOI: 10.3390/foods14030347.


Interpreting the role of epigallocatechin-3-gallate in Epstein-Barr virus infection-mediated neuronal diseases.

Rani A, Saini V, Njini N, Dixit A, Meena A, Jha H Folia Microbiol (Praha). 2025; .

PMID: 39849283 DOI: 10.1007/s12223-025-01240-0.


Beneficial Effects of Epigallocatechin Gallate in Preventing Skin Photoaging: A Review.

Sun J, Jiang Y, Fu J, He L, Guo X, Ye H Molecules. 2024; 29(22).

PMID: 39598619 PMC: 11596539. DOI: 10.3390/molecules29225226.


Harnessing the Anti-Inflammatory Properties of Polyphenols in the Treatment of Inflammatory Bowel Disease.

Boaru D, Fraile-Martinez O, De Leon-Oliva D, Garcia-Montero C, De Castro-Martinez P, Miranda-Gonzalez A Int J Biol Sci. 2024; 20(14):5608-5672.

PMID: 39494333 PMC: 11528451. DOI: 10.7150/ijbs.98107.


Mitoepigenetics pathways and natural compounds: a dual approach to combatting hepatocellular carcinoma.

Hatawsh A, Al-Haddad R, Okafor U, Diab L, Dekanoidze N, Abdulwahab A Med Oncol. 2024; 41(12):302.

PMID: 39465473 DOI: 10.1007/s12032-024-02538-8.


References
1.
Jomova K, Valko M . Advances in metal-induced oxidative stress and human disease. Toxicology. 2011; 283(2-3):65-87. DOI: 10.1016/j.tox.2011.03.001. View

2.
Abolhassani N, Leon J, Sheng Z, Oka S, Hamasaki H, Iwaki T . Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain. Mech Ageing Dev. 2016; 161(Pt A):95-104. DOI: 10.1016/j.mad.2016.05.005. View

3.
Hudson S, Ecroyd H, Dehle F, Musgrave I, Carver J . (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway. J Mol Biol. 2009; 392(3):689-700. DOI: 10.1016/j.jmb.2009.07.031. View

4.
Choi Y, Jeong Y, Lee Y, Kwon H, Kang Y . (-)Epigallocatechin gallate and quercetin enhance survival signaling in response to oxidant-induced human endothelial apoptosis. J Nutr. 2005; 135(4):707-13. DOI: 10.1093/jn/135.4.707. View

5.
Mika M, Kostogrys R, Franczyk-Zarow M, Wikiera A, Maslak E . Anti-atherosclerotic activity of catechins depends on their stereoisomerism. Atherosclerosis. 2015; 240(1):125-30. DOI: 10.1016/j.atherosclerosis.2015.02.026. View